|
Long Term Treatment of Patients with Major Depressive Disorder with an Investigational Compound Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Long Term Treatment of Patients with Major Depressive Disorder with an Investigational Compound conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Long Term Treatment of Patients with Major Depressive Disorder with an Investigational Compound Clinical research trials and Long Term Treatment of Patients with Major Depressive Disorder with an Investigational Compound healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Long Term Treatment of Patients with Major Depressive Disorder with an Investigational Compound. Long Term Treatment of Patients with Major Depressive Disorder with an Investigational Compound Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Long Term Treatment of Patients with Major Depressive Disorder with an Investigational Compound clinical trial. Test subjects typically receive the most effective healthcare possible for their Long Term Treatment of Patients with Major Depressive Disorder with an Investigational Compound condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "L" Clinical Trials Conditions > Long Term Treatment of Patients with Major Depressive Disorder with an Investigational Compound Long Term Treatment of Patients with Major Depressive Disorder with an Investigational Compound
Long Term Treatment of Patients with Major Depressive Disorder with an Investigational Compound
For Condition: Major Depressive Disorder
Status: No longer recruiting
Sponsor(s): Sponsor Name Pending ,
Synopsis: A clinical study to determine the efficacy and safety of an investigational medication in the treatment of depression.
Details:
Eligibility:
Study Type: Interventional, Treatment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Patients with Major Depressive Disorder
Total Enrollment:
Location and Contact Information:
Call for Information
Baltimore, Maryland,
United States
Call for Information
Florence, Kentucky,
United States
Call for Information
San Bernardino, California,
United States
Call for Information
New York City, New York,
United States
Call for Information
Upland, California,
United States
Call for Information
Las Vegas, Nevada,
United States
Call for Information
Cincinnati, Ohio,
United States
Call for Information
Lawrence, New York,
United States
Call for Information
San Diego, California,
United States
Call for Information
Winter Park, Florida,
United States
Call for Information
St. Petersburg, Florida,
United States
Call for Information
Overland Park, Kansas,
United States
Call for Information
West Palm Beach, Florida,
United States
Call for Information
Phoenix, Arizona,
United States
Call for Information
Staten Island, New York,
United States
Additional Information:
Study ID Numbers: 35MRB2;
Study Start Date:
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00048594
Other Major Depressive Disorder Studies:
1. Treatment of Patients with Major Depressive Disorder with an Investigational Compound
2. Open Label Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
3. Brain Regulation of Emotions in People with Depression and Anhedonia
4. Therapy for Depression with Co-occurring Panic or Anxiety Symptoms
5. Long Term Treatment of Patients with Major Depressive Disorder with an Investigational Compound
Related Studies:
Other Major Depressive Disorder Clinical Trials
Other New York Clinical Trials
Other Staten Island Clinical Trials
Long Term Treatment of Patients with Major Depressive Disorder with an Investigational Compound
|
|
|
|
|
|
|
|